NalaGenetics key facts
- Developer of a personalized prescription platform designed to offer accurate testing, impactful outcomes and localized recommendations.
- It has raised $15.7M; the latest was Grant ($60K) in Jan 2025.
- Notable investors include Google for Startups, East Ventures, ACV Capital, Cercano Management, SGInnovate — 21 tracked in total.
- Status: Privately Held (backing).
Who backs NalaGenetics
21+- ·The complete investor list: 21 names
- ·Watch NalaGenetics: the Monday email on marks, rounds and moves
NalaGenetics funding rounds
No funding rounds for NalaGenetics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
NalaGenetics investors
21 investors are on record for NalaGenetics, including Google for Startups, East Ventures, ACV Capital and Cercano Management.
About NalaGenetics
Developer of a personalized prescription platform designed to offer accurate testing, impactful outcomes and localized recommendations. The company's platform increases prescription efficacy through genetic testing and information management systems, enabling patients and decision-makers to have access to personalized information on how to interact with existing healthcare technologies.
- Sector
- Healthcare
- HQ
- Singapore, Singapore
- Founded
- 2016
- Employees
- 62
- Website
- nalagenetics.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
NalaGenetics doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.